Issued Patents All Time
Showing 1–25 of 36 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12398194 | Cell lexpressing two chimeric antigen receptors (CARs) at the cell surface | Martin Pulé, Shimobi Onuoha, Simon Thomas | 2025-08-26 |
| 12325733 | Binding domain | Anna Bulek, Martin Pulé, Simon Thomas, Shimobi Onuoha, Mathieu Ferrari +1 more | 2025-06-10 |
| 12241068 | CD79-specific chimeric antigen receptor | Martin Pulé, Simon Thomas, Shimobi Onuoha, Mathieu Ferrari | 2025-03-04 |
| 12234295 | Chimeric transmembrane protein comprising antibody dimerization domains and a type I cytokine receptor endodomain, encoding nucleic acids thereof and methods of use thereof | Martin Pulé, Matteo Righi, James Sillibourne, Shimobi Onuoha, Simon Thomas | 2025-02-25 |
| 12187769 | Cell | Martin Pulé, Simon Thomas, Shimobi Onuoha, Matteo Righi | 2025-01-07 |
| 12049510 | Chimeric antigen receptor | Martin Pulé, Simon Thomas, Shimobi Onuoha, Mathieu Ferrari, Wen Chean Lim +1 more | 2024-07-30 |
| 11963981 | Chimeric antigen receptor | Martin Pulé, Evangelia Kokalaki, Shimobi Onuoha, Simon Thomas, Biao Ma +1 more | 2024-04-23 |
| 11959084 | Nucleic acid construct | James Sillibourne, Martin Pulé | 2024-04-16 |
| 11851672 | CAR T-cells comprising transcriptional circuits | Martin Pulé, James Sillibourne | 2023-12-26 |
| 11701386 | Cell | Martin Pulé, Simon Thomas, Shimobi Onuoha, Matteo Righi | 2023-07-18 |
| 11648274 | Polypeptide | Martin Pulé, Matteo Righi, Simon Thomas, Shimobi Onuoha | 2023-05-16 |
| 11613559 | Nucleic acid construct | Martin Pulé | 2023-03-28 |
| 11590170 | Chimeric antigen receptor | Martin Pulé, Evangelia Kokalaki, Shimobi Onuoha, Simon Thomas, Biao Ma +1 more | 2023-02-28 |
| 11530420 | Nucleic acid construct | Martin Pulé | 2022-12-20 |
| 11479613 | Methods for treating cancer or modulating T cells or NK cells in a subject by administering cells comprising chimeric transmembrane proteins | Martin Pulé, Matteo Righi, James Sillibourne, Shimobi Onuoha, Simon Thomas | 2022-10-25 |
| 11479614 | Methods for treating cancer or modulating T cells or NK cells in a subject with cancer by administering cells comprising chimeric cytokine receptors | Martin Pulé, Matteo Righi, James Sillibourne, Shimobi Onuoha, Simon Thomas | 2022-10-25 |
| 11466070 | Signalling system | Martin Pulé, Simon Thomas, Shimobi Onuoha, Maria Stavrou | 2022-10-11 |
| 11440961 | Anti TRBC1 antigen binding domains | Simon Thomas, Shimobi Onuoha, Ram Jha, Wen Chean Lim | 2022-09-13 |
| 11434293 | Anti TRBC1 antigen binding domains | Simon Thomas, Shimobi Onuoha, Ram Jha, Wen Chean Lim | 2022-09-06 |
| 11365262 | Cell | Martin Pulé, Matteo Righi, James Sillibourne | 2022-06-21 |
| 11345734 | Chimeric T cell | Martin Pulé, Simon Thomas, Khai Kong | 2022-05-31 |
| 11242377 | Chimeric receptor with ligand binding exodomain and cytokine and T cell signalling endodomains | Martin Pulé, Matteo Righi | 2022-02-08 |
| 11180553 | Chimeric antigen receptor | Shimobi Onuoha, Martin Pulé, Simon Thomas, Evangelia Kokalaki | 2021-11-23 |
| 11091532 | T cell which co-expresses a CD19 chimeric antigen receptor and a CD22 chimeric antigen receptor | Martin Pulé, Shimobi Onuoha, Simon Thomas | 2021-08-17 |
| 11058722 | Chimeric antigen receptor comprising a cartilage-oligomeric matrix protein (comp) coiled-coil spacer domain | Martin Pulé | 2021-07-13 |